News Related to AGT (angiotensinogen)

Related coverage linked through entity extraction aliases.

CRISPR Therapeutics says CASGEVY momentum is building as zugo-cel and other pipeline data near

May 16, 2026

CRISPR Therapeutics said CASGEVY launch momentum is building and multiple pipeline assets could generate data in the next 12 to 18 months. The company also highlighted zugo-cel progress in oncology and autoimmune disease.

Twice-Yearly Injections May Transform Hypertension Treatment, Lancet Review Finds

Feb 14, 2026

A review in The Lancet highlights emerging long-acting injectable therapies for hypertension that could reduce treatment to two doses annually instead of daily pills, with several candidates now in late-stage clinical trials.